A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

NCT06938321 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: AK112
DRUG: AK130

Sponsor

Akeso